TABLE 5.
Antigen-Wise Coverage Estimates (%)
| Birth | 6 weeks | 10 weeks | 14 weeks | 9 months | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCG | OPV0 | OPV1 | PENTA1 | PCV1 | RV1 | OPV2 | PENTA2 | PCV2 | RV2 | OPV3 | PENTA3 | PCV3 | IPV | MCV1 | |
| Pakistan* | 93.8 | 92.5 | 92.4 | 90.8 | 90.5 | 89.7 | 88.2 | 87.5 | 87.1 | 85.3 | 84.2 | 83.5 | 82.8 | 84.2 | 80.5 |
| Provinces and regions | |||||||||||||||
| Punjab | 99.2 | 98.5 | 98.6 | 98.3 | 98.2 | 97.6 | 97.3 | 97.1 | 96.8 | 95.6 | 95.0 | 94.9 | 94.5 | 95.4 | 92.6 |
| Sindh | 92.5 | 90.9 | 89.1 | 86.3 | 85.8 | 84.6 | 81.4 | 79.7 | 79.2 | 76.2 | 75.0 | 73.2 | 71.5 | 73.7 | 67.2 |
| Khyber Pakhtunkhwa | 88.0 | 85.9 | 86.7 | 84.6 | 83.9 | 83.2 | 80.5 | 79.8 | 79.3 | 77.7 | 75.3 | 74.3 | 73.7 | 75.9 | 73.1 |
| FATA (KP-NMD) | 63.5 | 58.3 | 61.6 | 59.8 | 59.0 | 59.2 | 55.1 | 54.0 | 53.7 | 53.4 | 51.2 | 49.6 | 49.5 | 51.3 | 49.5 |
| Balochistan | 63.1 | 58.0 | 63.1 | 54.2 | 53.5 | 53.0 | 51.0 | 47.7 | 47.4 | 46.4 | 45.3 | 42.2 | 42.0 | 44.7 | 42.7 |
| Islamabad | 96.9 | 96.0 | 95.1 | 94.5 | 94.1 | 93.1 | 85.9 | 92.5 | 92.1 | 90.8 | 80.4 | 86.3 | 86.2 | 88.1 | 81.8 |
| AJK | 98.9 | 98.8 | 98.9 | 98.6 | 98.6 | 98.2 | 97.6 | 97.9 | 97.9 | 97.4 | 93.0 | 95.4 | 95.6 | 95.9 | 93.2 |
| GB | 93.6 | 93.8 | 95.0 | 90.0 | 89.4 | 85.9 | 90.2 | 86.8 | 86.4 | 81.7 | 84.8 | 82.2 | 81.1 | 83.7 | 81.2 |
AJK, Azad Jammu & Kashmir; BCG, Bacille Calmette-Guérin; GB, Gilgit Baltistan; IPV, Inactivated Polio Vaccine; KP: Khyber Pakhtunkhwa; FATA, Federally Administered Tribal Authority; KP-NMD, Khyber Pakhtunkhwa’s newly merged districts; MCV, Meningococcal Conjugate Vaccine; OPV, Oral Polio Vaccine; PCV, Pneumococcal Conjugate Vaccine; Penta, Pentavalent Vaccine; RV: Rota Virus.
*
Excludes AJK and GB.